• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

November 24, 2020

Gender-Based Trends, Physician Support Influence Medical Cannabis Use, Prescription Discontinuation

Author(s):

Aislinn Antrim, Assistant Editor

According to the study results, women interested in medical cannabis reported marginally lower levels of support from their primary care provider and significantly less support from specialist physicians.

A new study of gender differences in cannabis use has found that women are more likely to use medical cannabis for a range of conditions and to have increased use of cannabis since qualifying for medical use, although they also reported lower levels of physician support.1

The cross-sectional study found multiple gender-associated patterns in medical use, including differing levels of primary care provider support. According to the study results, women reported marginally lower levels of support from their primary care provider, and significantly less support from specialist physicians. Notably, a majority of women in the study successfully integrated medical cannabis into their chronic condition management, despite reporting just a moderate level of support from practitioners and specialists.

Recent findings from previous studies have found that men are more likely to be experienced cannabis users before the onset of medical use, although women are more likely to substitute medical cannabis for prescription medications. The study investigators confirmed that male participants were more likely to report use before qualification for medical cannabis, whereas among prior cannabis users, women were more likely to report that their use of cannabis increased after initiation of medical use.

The investigators also noted that after performing a multivariable analysis, being female, treating more symptoms with medical cannabis, and having a higher level of physician support is significantly associated with discontinuation of prescription medication use. Given that earlier studies have found that women engage more than men in complimentary or alternative medicine (CAM) services, the authors said the lack of requirement for a medical cannabis prescription in some places may contribute to more women conceptualizing of medical cannabis as a CAM service.

Further, medical cannabis users reported a range of motivations for discontinuing prescription medications, including concerns around addiction and toxicities, as well as better management of symptoms and side effects through medical cannabis use. According to the study authors, one implication of this finding could be for primary care providers who use medical cannabis to track patients’ usage and openly discuss their experiences during office visits. The authors noted that discontinuing prescriptions after noticing reductions in usage coupled with neutral attitudes of physicians toward medical cannabis could be perceived as support for continued usage.

Finally, the authors said that given precious study findings, there may be differences in provider support for discontinuing prescriptions depending on medications and patient conditions. Notably, the investigators did not ask participants to characterize physician responses to the lack of their prescription refills, but they said the interaction between patients and providers in this situation warrants further research.

REFERENCE

  • Bruce D, Grove T, Foster E, and Shattell M. Gender Differences in Medical Cannabis Use: Symptoms Treated, Physician Support for Use, and Prescription Medication Discontinuation. Journal of Women’s Health; October 22, 2020. Accessed November 20, 2020. https://www.liebertpub.com/doi/10.1089/jwh.2020.8437.

Related Videos
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
Image credit: AminaDesign | stock.adobe.com
May 23rd 2025

Oral GLP-1 Agonist Orforglipron Shows Promise for Type 2 Diabetes and Weight Management

Kennedy Ferruggia, Assistant Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Red ribbon for HIV/AIDS awareness -- Image credit: fizkes | stock.adobe.com
May 23rd 2025

A Student Pharmacist’s Guide to HIV Medications

Zahara Anglin, PharmD Candidate
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Skincare foam -- Image credit: Pavel | stock.adobe.com
Published: May 22nd 2025 | Updated: May 22nd 2025

FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children

Gillian McGovern, Associate Editor
Visualization of human body with COPD highlighted on lungs | Image Credit: © Lila Patel - stock.adobe.com
May 22nd 2025

FDA Approves Mepolizumab for Treatment of Patients With COPD and an Eosinophilic Phenotype

Alexandra Gerlach, Associate Editor
Related Content
Advertisement
Image credit: AminaDesign | stock.adobe.com
May 23rd 2025

Oral GLP-1 Agonist Orforglipron Shows Promise for Type 2 Diabetes and Weight Management

Kennedy Ferruggia, Assistant Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Red ribbon for HIV/AIDS awareness -- Image credit: fizkes | stock.adobe.com
May 23rd 2025

A Student Pharmacist’s Guide to HIV Medications

Zahara Anglin, PharmD Candidate
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Skincare foam -- Image credit: Pavel | stock.adobe.com
Published: May 22nd 2025 | Updated: May 22nd 2025

FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children

Gillian McGovern, Associate Editor
Visualization of human body with COPD highlighted on lungs | Image Credit: © Lila Patel - stock.adobe.com
May 22nd 2025

FDA Approves Mepolizumab for Treatment of Patients With COPD and an Eosinophilic Phenotype

Alexandra Gerlach, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.